132 related articles for article (PubMed ID: 12538005)
1. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.
Yous S; Durieux-Poissonnier S; Lipka-Belloli E; Guelzim H; Bochu C; Audinot V; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
Bioorg Med Chem; 2003 Mar; 11(5):753-9. PubMed ID: 12538005
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II.
Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S
Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
Wallez V; Durieux-Poissonnier S; Chavatte P; Boutin JA; Audinot V; Nicolas JP; Bennejean C; Delagrange P; Renard P; Lesieur D
J Med Chem; 2002 Jun; 45(13):2788-800. PubMed ID: 12061881
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
Descamps-François C; Yous S; Chavatte P; Audinot V; Bonnaud A; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
J Med Chem; 2003 Mar; 46(7):1127-9. PubMed ID: 12646022
[TBL] [Abstract][Full Text] [Related]
6. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.
Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM
Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells.
Nonno R; Lucini V; Pannacci M; Mazzucchelli C; Angeloni D; Fraschini F; Stankov BM
Br J Pharmacol; 1998 Jun; 124(3):485-92. PubMed ID: 9647472
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands.
Mor M; Spadoni G; Di Giacomo B; Diamantini G; Bedini A; Tarzia G; Plazzi PV; Rivara S; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
Bioorg Med Chem; 2001 Apr; 9(4):1045-57. PubMed ID: 11354661
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydronaphthalenic derivatives as new agonist and antagonist ligands for melatonin receptors.
Fourmaintraux E; Depreux P; Lesieur D; Guardiola-Lemaître B; Bennejean C; Delagrange P; Howell HE
Bioorg Med Chem; 1998 Jan; 6(1):9-13. PubMed ID: 9502101
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active melatonin MT(1) receptors in male rat caudal arteries.
Erşahin C; Masana MI; Dubocovich ML
Eur J Pharmacol; 2002 Mar; 439(1-3):171-2. PubMed ID: 11937107
[TBL] [Abstract][Full Text] [Related]
11. Methods for the evaluation of drug action at the human melatonin receptor subtypes.
Nonno R; Fraschini F; Stankov BM
Biol Signals Recept; 1999; 8(1-2):32-40. PubMed ID: 10085460
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated modulation of avian caecal muscle contraction by melatonin: role of tyrosine protein kinase.
Poon AM; Kravtsov GM; Pang SF
J Pineal Res; 2002 Apr; 32(3):199-208. PubMed ID: 12074105
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
Mésangeau C; Pérès B; Descamps-François C; Chavatte P; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Bennejean C; Renard P; Caignard DH; Berthelot P; Yous S
Bioorg Med Chem; 2010 May; 18(10):3426-36. PubMed ID: 20444610
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new arylalkoxy amido derivatives as melatoninergic ligands.
Pégurier C; Morellato L; Chahed E; Andrieux J; Nicolas JP; Boutin JA; Bennejean C; Delagrange P; Langlois M; Mathé-Allainmat M
Bioorg Med Chem; 2003 Mar; 11(5):789-800. PubMed ID: 12538010
[TBL] [Abstract][Full Text] [Related]
15. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
[TBL] [Abstract][Full Text] [Related]
16. Design of subtype selective melatonin receptor agonists and antagonists.
Sugden D; Yeh LK; Teh MT
Reprod Nutr Dev; 1999; 39(3):335-44. PubMed ID: 10420436
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of new melatonin dimeric derivatives.
Di Giacomo B; Bedini A; Spadoni G; Tarzia G; Fraschini F; Pannacci M; Lucini V
Bioorg Med Chem; 2007 Jul; 15(13):4643-50. PubMed ID: 17481904
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
19. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
